Eligibility for faricimab in a real-world diabetic macular oedema population: a cross-sectional study
Purpose To investigate the eligibility for faricimab in a real-world diabetic macular oedema (DMO) population to the YOSEMITE and RHINE trials, and to compare the eligible DMO populations to the trial populations.Design, settings and participants This retrospective cross-sectional analysis used data...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-02-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/2/e089801.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|